Ep 24: Insitro CEO Daphne Koller on Using ML to Change Drug Discovery
Release Date:
Jacob sits down with Insitro CEO Daphne Koller to discuss founding Coursera, where and how ML can drive the most impact in drug development, and if foundation models can transform core drug discovery work and edtech. 00:00 intro00:59 Daphne’s journey09:02 AI and biology discovery10:42 insitro vs. traditional pharma19:47 phenotyping patients25:44 early mistakes29:34 the future of data35:16 partnering with larger pharma companies38:00 impact of LLMs on biopharma43:47 over-hyped/under-hyped
Ep 24: Insitro CEO Daphne Koller on Using ML to Change Drug Discovery